Article
Next generation self-replicating RNA vectors for vaccines and immunotherapies
22 Feb 2022
Abstract excerpt
RNA technology has recently come to the forefront of innovative medicines and is being explored for a wide range of therapies, including prophylactic and therapeutic vaccines, biotherapeutic protein expression and gene therapy. In addition to conventional mRNA platforms now approved for prophylactic SARS-CoV2 vaccines, synthetic self-replicating RNA vaccines are currently being evaluated in the clinic for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
